MD Magazine: Condition Center: Diabetes Copyright (c) 2017 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/conditions/diabetes-resources/rss Diabetes en-us Mon, 23 Jul 2018 09:53:18 +0000 Understanding, Valuing The Medical Journey to Weight Loss http://www.mdmag.com/medical-news/understanding-valuing-the-medical-journey-to-weight-loss http://www.mdmag.com/medical-news/understanding-valuing-the-medical-journey-to-weight-loss Wed, 18 Jul 2018 13:00:00 +0000 Janssen Ends Canagliflozin CREDENCE Trial Early After Hitting T2D, CKD Endpoints http://www.mdmag.com/medical-news/janssen-ends-canagliflozin-credence-trial-early-after-hitting-t2d-ckd-endpoints http://www.mdmag.com/medical-news/janssen-ends-canagliflozin-credence-trial-early-after-hitting-t2d-ckd-endpoints Mon, 16 Jul 2018 21:33:00 +0000 Charles Modlin, MD: The Man Working to Make Healthcare Care About Black Men http://www.mdmag.com/sap-partner/cleveland-clinic/charles-modlin-md-the-man-working-to-make-healthcare-care-about-black-men http://www.mdmag.com/sap-partner/cleveland-clinic/charles-modlin-md-the-man-working-to-make-healthcare-care-about-black-men Thu, 12 Jul 2018 11:00:00 +0000 In Vitro Model Provides Evidence for C3a Antagonists as AMD Therapy http://www.mdmag.com/medical-news/in-vitro-model-provides-evidence-for-c3a-antagonists-as-amd-therapy http://www.mdmag.com/medical-news/in-vitro-model-provides-evidence-for-c3a-antagonists-as-amd-therapy Wed, 11 Jul 2018 13:00:00 +0000 Outcomes Trials Examining Triglycerides in CVD Risk http://www.mdmag.com/conference-coverage/ada-2018/outcomes-trials-examining-triglycerides-in-cvd-risk http://www.mdmag.com/conference-coverage/ada-2018/outcomes-trials-examining-triglycerides-in-cvd-risk Sun, 08 Jul 2018 11:00:00 +0000 HCV Status Not Linked to Diabetes in Patients with HIV http://www.mdmag.com/medical-news/hcv-status-not-linked-to-diabetes-in-patients-with-hiv http://www.mdmag.com/medical-news/hcv-status-not-linked-to-diabetes-in-patients-with-hiv Fri, 06 Jul 2018 13:00:00 +0000 Metformin Could Accelerate Idiothatic Pulmonary Fibrosis Care http://www.mdmag.com/medical-news/metformin-could-accelerate-idiothatic-pulmonary-fibrosis-reversal http://www.mdmag.com/medical-news/metformin-could-accelerate-idiothatic-pulmonary-fibrosis-reversal Thu, 05 Jul 2018 15:55:00 +0000 Healthy Lifestyle Among Mothers Significantly Impacts Child's Risk of Obesity http://www.mdmag.com/medical-news/healthy-lifestyle-among-mothers-significantly-impacts-childs-risk-of-obesity http://www.mdmag.com/medical-news/healthy-lifestyle-among-mothers-significantly-impacts-childs-risk-of-obesity Thu, 05 Jul 2018 09:00:00 +0000 Atrial Fibrillation Symptom Risks Reduced by Rivaroxaban http://www.mdmag.com/medical-news/atrial-fibrillation-symptom-risks-reduced-by-rivaroxaban http://www.mdmag.com/medical-news/atrial-fibrillation-symptom-risks-reduced-by-rivaroxaban Wed, 04 Jul 2018 15:11:00 +0000 Tim Dunn, PhD: Using Study Analysis to Inform Device Use http://www.mdmag.com/conference-coverage/ada-2018/tim-dunn-phd-using-study-analysis-to-inform-device-use http://www.mdmag.com/conference-coverage/ada-2018/tim-dunn-phd-using-study-analysis-to-inform-device-use Sun, 01 Jul 2018 11:00:00 +0000 Freestyle Libre's Data-Driven Approach to Diabetes http://www.mdmag.com/conference-coverage/ada-2018/freestyle-libres-data-driven-approach-to-diabetes http://www.mdmag.com/conference-coverage/ada-2018/freestyle-libres-data-driven-approach-to-diabetes Sun, 01 Jul 2018 09:00:00 +0000 Canagliflozin Does Not Increase Risk of Amputation, Despite Boxed Warning http://www.mdmag.com/conference-coverage/ada-2018/canagliflozin-does-not-increase-risk-of-amputation-despite-boxed-warning http://www.mdmag.com/conference-coverage/ada-2018/canagliflozin-does-not-increase-risk-of-amputation-despite-boxed-warning Fri, 29 Jun 2018 13:00:00 +0000 The Role of Leptin in Obesity, Type 2 Diabetes, Other Metabolic Conditions http://www.mdmag.com/conference-coverage/ada-2018/the-role-of-leptin-in-obesity-type-2-diabetes-other-metabolic-conditions http://www.mdmag.com/conference-coverage/ada-2018/the-role-of-leptin-in-obesity-type-2-diabetes-other-metabolic-conditions Fri, 29 Jun 2018 11:00:00 +0000 Trang Ly, MBBS, FRACP, PhD: Integrative Technology in Diabetes Management http://www.mdmag.com/conference-coverage/ada-2018/trang-ly-mbbs-fracp-phd-integrative-technology-in-diabetes-management http://www.mdmag.com/conference-coverage/ada-2018/trang-ly-mbbs-fracp-phd-integrative-technology-in-diabetes-management Thu, 28 Jun 2018 13:00:00 +0000 Hiten Chawla, MBA: Changing the Diabetes Game with New Devices, Telehealth http://www.mdmag.com/conference-coverage/ada-2018/hiten-chawla-mba-changing-the-diabetes-game-with-new-devices-telehealth http://www.mdmag.com/conference-coverage/ada-2018/hiten-chawla-mba-changing-the-diabetes-game-with-new-devices-telehealth Wed, 27 Jun 2018 14:04:00 +0000 Hybrid Closed Loop System Shows Improved Glycemic Control in T1D http://www.mdmag.com/conference-coverage/ada-2018/hybrid-closed-loop-system-shows-improved-glycemic-control-in-t1d http://www.mdmag.com/conference-coverage/ada-2018/hybrid-closed-loop-system-shows-improved-glycemic-control-in-t1d Wed, 27 Jun 2018 11:00:00 +0000 Peter Toth, MD: GLP-1 Agonists and SGLT-2 Inhibitors for Diabetes http://www.mdmag.com/conference-coverage/ada-2018/peter-toth-md-glp1-agonists-and-sglt2-inhibitors-for-diabetes http://www.mdmag.com/conference-coverage/ada-2018/peter-toth-md-glp1-agonists-and-sglt2-inhibitors-for-diabetes Tue, 26 Jun 2018 16:46:00 +0000 Trends in Insulin Pen Priming for Patients with Type 1 Diabetes http://www.mdmag.com/conference-coverage/ada-2018/trends-in-insulin-pen-priming-for-patients-with-type-1-diabetes http://www.mdmag.com/conference-coverage/ada-2018/trends-in-insulin-pen-priming-for-patients-with-type-1-diabetes Tue, 26 Jun 2018 16:28:00 +0000 Andrea Dunaif, MD: Cardiovascular Disease in Women http://www.mdmag.com/conference-coverage/ada-2018/andrea-dunaif-md-cardiovascular-disease-in-women http://www.mdmag.com/conference-coverage/ada-2018/andrea-dunaif-md-cardiovascular-disease-in-women Tue, 26 Jun 2018 14:00:00 +0000 Andrea Dunaif, MD: PCOS Prevalence in Women with Type 2 Diabetes http://www.mdmag.com/conference-coverage/ada-2018/andrea-dunaif-md-pcos-prevalence-in-women-with-type-2-diabetes http://www.mdmag.com/conference-coverage/ada-2018/andrea-dunaif-md-pcos-prevalence-in-women-with-type-2-diabetes Mon, 25 Jun 2018 17:02:00 +0000 Meal Replacement Program Shows Glycemic, Weight Improvements for Patients With T2D, Obesity http://www.mdmag.com/conference-coverage/ada-2018/meal-replacement-program-shows-glycemic-weight-improvements-for-patients-with-t2d-obesity http://www.mdmag.com/conference-coverage/ada-2018/meal-replacement-program-shows-glycemic-weight-improvements-for-patients-with-t2d-obesity Mon, 25 Jun 2018 16:45:00 +0000 Insulin Glargine Reports Non-Inferior T2D Control to Degludec in BRIGHT Study http://www.mdmag.com/conference-coverage/ada-2018/insulin-glargine-reports-t2d-control-noninferiority-to-degludec-in-bright-study http://www.mdmag.com/conference-coverage/ada-2018/insulin-glargine-reports-t2d-control-noninferiority-to-degludec-in-bright-study Mon, 25 Jun 2018 15:30:00 +0000 The Debate About SGLT-2 Inhibitors and GLP-1 Receptor Agonists http://www.mdmag.com/conference-coverage/ada-2018/the-debate-about-sglt2-inhibitors-and-glp1-receptor-agonists http://www.mdmag.com/conference-coverage/ada-2018/the-debate-about-sglt2-inhibitors-and-glp1-receptor-agonists Mon, 25 Jun 2018 11:00:00 +0000 Hiten Chawla, MBA: Expanded Indications, Real-World Results for Closed Hybrid Loop System http://www.mdmag.com/conference-coverage/ada-2018/hiten-chawla-mba-expanded-indications-realworld-results-for-closed-hybrid-looped-system http://www.mdmag.com/conference-coverage/ada-2018/hiten-chawla-mba-expanded-indications-realworld-results-for-closed-hybrid-looped-system Sun, 24 Jun 2018 22:05:00 +0000 Girls with Type 1 Diabetes More Likely to Have Suicidal Ideation http://www.mdmag.com/conference-coverage/ada-2018/girls-with-type-1-diabetes-more-likely-to-have-suicidal-ideation http://www.mdmag.com/conference-coverage/ada-2018/girls-with-type-1-diabetes-more-likely-to-have-suicidal-ideation Sun, 24 Jun 2018 21:15:00 +0000 Rogelio Braceras, MD: Improving Costs, Comorbidities in T2D http://www.mdmag.com/conference-coverage/ada-2018/rogelio-braceras-md-improving-costs-comorbidities-in-t2d http://www.mdmag.com/conference-coverage/ada-2018/rogelio-braceras-md-improving-costs-comorbidities-in-t2d Sun, 24 Jun 2018 20:35:00 +0000 Alirocumab Plus Statin Lowers Cardiac Event Risk for Patients with Diabetes, ACS http://www.mdmag.com/conference-coverage/ada-2018/alirocumab-plus-statin-lowers-cardiac-event-risk-for-patients-with-diabetes-acs http://www.mdmag.com/conference-coverage/ada-2018/alirocumab-plus-statin-lowers-cardiac-event-risk-for-patients-with-diabetes-acs Sun, 24 Jun 2018 18:51:00 +0000 Empagliflozin Reduces Renal Risks, Heart Failure Hospitalization in T2D Patients http://www.mdmag.com/conference-coverage/ada-2018/empagliflozin-reduces-renal-risks-heart-failure-hospitalization-in-t2d-patients http://www.mdmag.com/conference-coverage/ada-2018/empagliflozin-reduces-renal-risks-heart-failure-hospitalization-in-t2d-patients Sun, 24 Jun 2018 01:02:00 +0000 Robert Gabbay, MD, PhD: The Role of Patient-Provider Communication in Medication Adherence http://www.mdmag.com/conference-coverage/ada-2018/robert-gabbay-md-phd-the-role-of-patientprovider-communication-in-medication-adherence http://www.mdmag.com/conference-coverage/ada-2018/robert-gabbay-md-phd-the-role-of-patientprovider-communication-in-medication-adherence Sat, 23 Jun 2018 23:32:00 +0000 Insulin Degludec and Liraglutide Improves Add-on T2D Therapy in DUAL IX Trial http://www.mdmag.com/conference-coverage/ada-2018/insulin-degludec-and-liraglutide-improves-addon-t2d-therapy-in-dual-ix-trial http://www.mdmag.com/conference-coverage/ada-2018/insulin-degludec-and-liraglutide-improves-addon-t2d-therapy-in-dual-ix-trial Sat, 23 Jun 2018 23:15:00 +0000